253 related articles for article (PubMed ID: 29453094)
1. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
[TBL] [Abstract][Full Text] [Related]
2. New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.
Kun S; Bokor É; Varga G; Szőcs B; Páhi A; Czifrák K; Tóth M; Juhász L; Docsa T; Gergely P; Somsák L
Eur J Med Chem; 2014 Apr; 76():567-79. PubMed ID: 24608000
[TBL] [Abstract][Full Text] [Related]
3. Probing the β-pocket of the active site of human liver glycogen phosphorylase with 3-(C-β-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors.
Kyriakis E; Solovou TGA; Kun S; Czifrák K; Szőcs B; Juhász L; Bokor É; Stravodimos GA; Kantsadi AL; Chatzileontiadou DSM; Skamnaki VT; Somsák L; Leonidas DD
Bioorg Chem; 2018 Apr; 77():485-493. PubMed ID: 29454281
[TBL] [Abstract][Full Text] [Related]
4. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L
Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of New C- and N-β-d-Glucopyranosyl Derivatives of Imidazole, 1,2,3-Triazole and Tetrazole, and Their Evaluation as Inhibitors of Glycogen Phosphorylase.
Kun S; Bokor É; Sipos Á; Docsa T; Somsák L
Molecules; 2018 Mar; 23(3):. PubMed ID: 29543771
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Barr D; Szennyes E; Bokor É; Al-Oanzi ZH; Moffatt C; Kun S; Docsa T; Sipos Á; Davies MP; Mathomes RT; Snape TJ; Agius L; Somsák L; Hayes JM
ACS Chem Biol; 2019 Jul; 14(7):1460-1470. PubMed ID: 31243960
[TBL] [Abstract][Full Text] [Related]
7. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, In Silico and Kinetics Evaluation of
Homolya L; Mathomes RT; Varga L; Docsa T; Juhász L; Hayes JM; Somsák L
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731811
[TBL] [Abstract][Full Text] [Related]
9. van der Waals interactions govern C-β-d-glucopyranosyl triazoles' nM inhibitory potency in human liver glycogen phosphorylase.
Kantsadi AL; Stravodimos GA; Kyriakis E; Chatzileontiadou DSM; Solovou TGA; Kun S; Bokor É; Somsák L; Leonidas DD
J Struct Biol; 2017 Jul; 199(1):57-67. PubMed ID: 28483603
[TBL] [Abstract][Full Text] [Related]
10. C-Glucopyranosyl-1,2,4-triazol-5-ones: synthesis and inhibition of glycogen phosphorylase.
Bokor É; Széles Z; Docsa T; Gergely P; Somsák L
Carbohydr Res; 2016 Jun; 429():128-34. PubMed ID: 26818133
[TBL] [Abstract][Full Text] [Related]
11. The σ-hole phenomenon of halogen atoms forms the structural basis of the strong inhibitory potency of C5 halogen substituted glucopyranosyl nucleosides towards glycogen phosphorylase b.
Kantsadi AL; Hayes JM; Manta S; Skamnaki VT; Kiritsis C; Psarra AM; Koutsogiannis Z; Dimopoulou A; Theofanous S; Nikoleousakos N; Zoumpoulakis P; Kontou M; Papadopoulos G; Zographos SE; Komiotis D; Leonidas DD
ChemMedChem; 2012 Apr; 7(4):722-32. PubMed ID: 22267166
[TBL] [Abstract][Full Text] [Related]
12. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
[TBL] [Abstract][Full Text] [Related]
13. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
Nagy V; Felföldi N; Kónya B; Praly JP; Docsa T; Gergely P; Chrysina ED; Tiraidis C; Kosmopoulou MN; Alexacou KM; Konstantakaki M; Leonidas DD; Zographos SE; Oikonomakos NG; Kozmon S; Tvaroška I; Somsák L
Bioorg Med Chem; 2012 Mar; 20(5):1801-16. PubMed ID: 22325154
[TBL] [Abstract][Full Text] [Related]
14. Nanomolar Inhibitors of Glycogen Phosphorylase Based on β-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.
Bokor É; Kyriakis E; Solovou TGA; Koppány C; Kantsadi AL; Szabó KE; Szakács A; Stravodimos GA; Docsa T; Skamnaki VT; Zographos SE; Gergely P; Leonidas DD; Somsák L
J Med Chem; 2017 Nov; 60(22):9251-9262. PubMed ID: 28925695
[TBL] [Abstract][Full Text] [Related]
15. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, enzyme kinetics and computational evaluation of N-(β-D-glucopyranosyl) oxadiazolecarboxamides as glycogen phosphorylase inhibitors.
Polyák M; Varga G; Szilágyi B; Juhász L; Docsa T; Gergely P; Begum J; Hayes JM; Somsák L
Bioorg Med Chem; 2013 Sep; 21(18):5738-47. PubMed ID: 23938052
[TBL] [Abstract][Full Text] [Related]
17. Halogen-substituted (C-β-D-glucopyranosyl)-hydroquinone regioisomers: synthesis, enzymatic evaluation and their binding to glycogen phosphorylase.
Alexacou KM; Zhang YZ; Praly JP; Zographos SE; Chrysina ED; Oikonomakos NG; Leonidas DD
Bioorg Med Chem; 2011 Sep; 19(17):5125-36. PubMed ID: 21821421
[TBL] [Abstract][Full Text] [Related]
18. Efficient atropodiastereoselective access to 5,5'-bis-1,2,3-triazoles: studies on 1-glucosylated 5-halogeno 1,2,3-triazoles and their 5-substituted derivatives as glycogen phosphorylase inhibitors.
Goyard D; Chajistamatiou AS; Sotiropoulou AI; Chrysina ED; Praly JP; Vidal S
Chemistry; 2014 Apr; 20(18):5423-32. PubMed ID: 24677199
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of heterocyclic N-(β-D-glucopyranosyl)carboxamides for inhibition of glycogen phosphorylase.
Kónya B; Docsa T; Gergely P; Somsák L
Carbohydr Res; 2012 Apr; 351():56-63. PubMed ID: 22365837
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of variously coupled conjugates of D-glucose, 1,3,4-oxadiazole, and 1,2,3-triazole for inhibition of glycogen phosphorylase.
Kun S; Nagy GZ; Tóth M; Czecze L; Van Nhien AN; Docsa T; Gergely P; Charavgi MD; Skourti PV; Chrysina ED; Patonay T; Somsák L
Carbohydr Res; 2011 Sep; 346(12):1427-38. PubMed ID: 21470596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
